Seller record · Telehealth service

ElixaMD

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the home page, the program page, the terms or the refund policy.

At a glance

ElixaMDTelehealth service

7/8criteria passed
Price
Compounded semaglutide program $99 for the first month on sale, then $199 a month, medication included
Sells
compounded semaglutide, Wegovy pill, Wegovy injection, and 1 more
FDA letters
None on file
Visit ElixaMDSee all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth weight loss service that sells a compounded semaglutide program with the medication included, after an online evaluation and review by clinicians from its affiliated medical groups, and also offers Wegovy and Zepbound for a membership fee plus the medication cost.

Operating entity ElixaMD, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSElixaMD's website; ElixaMD's GLP-1 storefront
S2Prescription gatingPASSElixaMD's GLP-1 storefront; ElixaMD's cancellation and refund policy
S3Pharmacy identificationPASSElixaMD's website
S4Compounding disclosurePASSElixaMD's website; ElixaMD's GLP-1 storefront
S5Analytical documentationFAILElixaMD's website; ElixaMD's GLP-1 storefront; ElixaMD's terms and conditions
S6Business addressPASSElixaMD's terms and conditions; ElixaMD's website
S7Price disclosurePASSElixaMD's GLP-1 storefront
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescriptions are issued only after an online consultation with an independent licensed provider, and clinicians from the affiliated medical groups decide whether to prescribe.Source: ElixaMD's website; ElixaMD's GLP-1 storefront.
S2PASSThe steps list an online evaluation reviewed by licensed professionals before any prescription, the answers to that assessment screen a person out before checkout, and the refund policy returns the charges in full if the provider disqualifies the patient.Source: ElixaMD's GLP-1 storefront; ElixaMD's cancellation and refund policy.
S3PASSThe footer names three partner pharmacies with street addresses: Triad Rx in Daphne, Alabama, RedRock Pharmacy in St. George, Utah, and Beaker Pharmacy & Compounding in McKinney, Texas.Source: ElixaMD's website.
S4PASSThe home page says compounded medications are dispensed by state-licensed pharmacies but are not FDA approved, and the footer of every page says they are not FDA-approved or evaluated for safety, efficacy or quality.Source: ElixaMD's website; ElixaMD's GLP-1 storefront.
S5FAILNo certificate of analysis or lot document is published on the home page, the program page, the terms or the refund policy.Source: ElixaMD's website; ElixaMD's GLP-1 storefront; ElixaMD's terms and conditions.
S6PASSElixaMD, LLC at 131 Continental Dr, Suite 305, Newark, DE 19713, printed in the terms and in the footer of every page.Source: ElixaMD's terms and conditions; ElixaMD's website.
S7PASSThe compounded semaglutide program costs $99 for the first month, advertised as a summer sale, and refills are $199 a month, with the physician review, plan and medication included. Wegovy and Zepbound options print a $99 membership plus the medication cost, with no medication price, while the same page says there is no membership fee.Source: ElixaMD's GLP-1 storefront.
S8PASSNo FDA warning letter names ElixaMD or ElixaMD, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, Wegovy pill, Wegovy injection, Zepbound injection.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Visit ElixaMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.